Cargando…

Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China

New diagnostic methods have provided a promising solution for rapid and reliable detection of drug-resistant TB strains. The aim of this study was to evaluate the performance of the MeltPro TB assay in identifying multidrug-resistant (MDR-) and extensively drug-resistant tuberculosis (XDR-TB) patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pang, Yu, Dong, Haiyan, Tan, Yaoju, Deng, Yunfeng, Cai, Xingshan, Jing, Hui, Xia, Hui, Li, Qiang, Ou, Xichao, Su, Biyi, Li, Xuezheng, Zhang, Zhiying, Li, Junchen, Zhang, Jiankang, Huan, Shitong, Zhao, Yanlin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858717/ https://www.ncbi.nlm.nih.gov/pubmed/27149911 http://dx.doi.org/10.1038/srep25330

Ejemplares similares

Performance of the MeltPro TB assay as initial test for diagnosis of pulmonary tuberculosis with drug-resistance detection
por: Liu, Zhi-bin, et al.
Publicado: (2023)

Evaluation of the MeltPro Myco Assay for the Identification of Non-Tuberculous Mycobacteria
por: Lin, Jian, et al.
Publicado: (2022)

The Burden of MDR/XDR Tuberculosis in Coastal Plains Population of China
por: Yang, Xiujun, et al.
Publicado: (2015)

MDR & XDR Tuberculosis
por: Kumar, Prahlad
Publicado: (2017)

Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use
por: Hafkin, Jeffrey, et al.
Publicado: (2017)

Risk Factors for MDR and XDR-TB in a Tertiary Referral Hospital in India
por: Balaji, V., et al.
Publicado: (2010)

Risk Factors for Poor Treatment Outcomes in Patients with MDR-TB and XDR-TB in China: Retrospective Multi-Center Investigation
por: Tang, Shenjie, et al.
Publicado: (2013)

Ability of the MeltPro MTB/PZA Assay to Detect Susceptibility to Pyrazinamide in Rifampin-Resistant Tuberculosis Patients
por: Li, Rong, et al.
Publicado: (2023)

Association of anti-tuberculosis drug concentrations in hair and treatment outcomes in MDR- and XDR-TB
por: Metcalfe, John, et al.
Publicado: (2019)

Multidrug-Resistant TB (MDR-TB) and Extensively Drug-Resistant TB (XDR-TB) Among Children: Where We Stand Now
por: Chowdhury, Kona, et al.
Publicado: (2023)

Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis Strains
por: Hameed, H. M. Adnan, et al.
Publicado: (2018)

Transmission of MDR and XDR Tuberculosis in Shanghai, China
por: Zhao, Ming, et al.
Publicado: (2009)

Clinical and socio-economic characteristics of a cohort of MDR/XDR TB patients in Bucharest, Romania
por: Ivanova, O, et al.
Publicado: (2023)

Predictive factors for unfavourable treatment in MDR-TB and XDR-TB patients in Rio de Janeiro State, Brazil, 2000-2016
por: Bhering, Marcela, et al.
Publicado: (2019)

Activity of Semi-Synthetic Mulinanes against MDR, Pre-XDR, and XDR Strains of Mycobacterium tuberculosis
por: Martínez-González, María Alejandrina, et al.
Publicado: (2021)

Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy
por: Codecasa, Luigi R., et al.
Publicado: (2017)

Characteristics and Treatment Outcomes of Patients with MDR and XDR Tuberculosis in a TB Referral Hospital in Beijing: A 13-Year Experience
por: Liu, Cui Hua, et al.
Publicado: (2011)

Linezolid-Associated Neuropathy in Patients with MDR/XDR Tuberculosis in Shenzhen, China
por: Zhang, Peize, et al.
Publicado: (2022)

XDR-TB in South Africa: Back to TB Sanatoria Perhaps?
por: Sakoane, Ramalitse
Publicado: (2007)

The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks
por: Sirgel, Frederick A., et al.
Publicado: (2013)

Analysing non-synonymous mutations in XDR and MDR tuberculosis drugs
por: Surana, Pallavi, et al.
Publicado: (2019)

MDR and XDR typhoid fever-a threat for the current decade?
por: Pustake, Manas, et al.
Publicado: (2021)

Epidemic Levels of Drug Resistant Tuberculosis (MDR and XDR-TB) in a High HIV Prevalence Setting in Khayelitsha, South Africa
por: Cox, Helen S., et al.
Publicado: (2010)

Evaluation of risk factors associated with the development of MDR- and XDR-TB in a tertiary care hospital: a retrospective cohort study
por: Saifullah, Amna, et al.
Publicado: (2021)

Experiences and needs of patients with MDR/XDR-TB: a qualitative study among Saharia tribe in Madhya Pradesh, Central India
por: Nigam, Samridhi, et al.
Publicado: (2021)

XDR-TB in South Africa: Revised Definition
por: Holtz, Timothy H
Publicado: (2007)

XDR-TB in South Africa: Detention Is Not the Priority
por: Goemaere, Eric, et al.
Publicado: (2007)

XDR-TB in South Africa: Theory and Practice
por: Andrews, Jason, et al.
Publicado: (2007)

Prevalence of pre-extensively drug-resistant tuberculosis (Pre XDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) among extra pulmonary (EP) multidrug resistant tuberculosis (MDR-TB) at a tertiary care center in Mumbai in pre Bedaquiline (BDQ) era
por: Utpat, Ketaki V., et al.
Publicado: (2023)

Correction: The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks
por: Sirgel, Frederick A., et al.
Publicado: (2015)

Age of Antibiotic Resistance in MDR/XDR Clinical Pathogen of Pseudomonas aeruginosa
por: Kothari, Ashish, et al.
Publicado: (2023)

XDR-TB in South Africa: No Time for Denial or Complacency
por: Singh, Jerome Amir, et al.
Publicado: (2007)

MDR TB Transmission, Singapore
por: Chee, Cynthia B.E., et al.
Publicado: (2013)

‘Z(S)-MDR-TB' versus ‘Z(R)-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility
por: Zhang, Ying, et al.
Publicado: (2012)

The Role of Adjunctive Therapies in Septic Shock by Gram Negative MDR/XDR Infections
por: Busani, Stefano, et al.
Publicado: (2017)

WHO's Response to Global Public Health Threats: XDR-TB
por: Wilson, Kumanan, et al.
Publicado: (2007)

Evaluation of the MTBDRplus 2.0 assay for the detection of multidrug resistance among persons with presumptive pulmonary TB in China
por: Tan, Yaoju, et al.
Publicado: (2017)

Resurgence of Polymyxin B for MDR/XDR Gram-Negative Infections: An Overview of Current Evidence
por: Garg, Suneel Kumar, et al.
Publicado: (2017)

Effectiveness and Nephrotoxicity of Intravenous Polymyxin B in Chinese Patients With MDR and XDR Nosocomial Pneumonia
por: Zeng, Huihui, et al.
Publicado: (2021)

Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort Study
por: Shi, Li, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bo3m9p189tan5h3hfmb27u53g5